Showing results (251-260 of 263) with videos related to
Sort By:
Pageof 27
Chemistry & Biology|November 21, 2007
CD1c presentation of synthetic glycolipid antigens with foreign alkyl branching motifsAnnemieke de Jong, Eva Casas Arce, Tan-Yun Cheng, et al.Journal of Agricultural and Food Chemistry|December 19, 2014
Anomericity of T-2 toxin-glucoside: masked mycotoxin in cereal cropsSusan P McCormick, Takayuki Kato, Chris M Maragos, et al.The Journal of Organic Chemistry|April 3, 2004
The intramolecular asymmetric Pauson-Khand cyclization as a novel and general stereoselective route to benzindene prostacyclins: synthesis of UT-15 (treprostinil)Robert M Moriarty, Neena Rani, Livia A Enache, et al.Chemmedchem|October 2, 2020
An Advanced Apralog with Increased in vitro and in vivo Activity toward Gram-negative Pathogens and Reduced ex vivo CochleotoxicityAmr Sonousi, Jonathan C K Quirke, Prabuddha Waduge, et al.Mbio|October 2, 2014
Identification and evaluation of improved 4'-O-(alkyl) 4,5-disubstituted 2-deoxystreptamines as next-generation aminoglycoside antibioticsStefan Duscha, Heithem Boukari, Dimitri Shcherbakov, et al.Journal of the American Chemical Society|December 3, 2019
Apralogs: Apramycin 5-<i>O</i>-Glycosides and Ethers with Improved Antibacterial Activity and Ribosomal Selectivity and Reduced Susceptibility to the Aminoacyltranserferase (3)-IV Resistance DeterminantJonathan C K Quirke, Parasuraman Rajasekaran, Vikram A Sarpe, et al.The Journal of Antimicrobial Chemotherapy|January 11, 2019
In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumanniiMario Juhas, Emma Widlake, Jeanette Teo, et al.RSC Medicinal Chemistry|August 6, 2021
Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitorsAnmol Gulati, Charles S Yeung, Blair Lapointe, et al.Journal of the American Chemical Society|February 23, 2019
Design, Multigram Synthesis, and in Vitro and in Vivo Evaluation of Propylamycin: A Semisynthetic 4,5-Deoxystreptamine Class Aminoglycoside for the Treatment of Drug-Resistant Enterobacteriaceae and Other Gram-Negative PathogensTakahiko Matsushita, Girish C Sati, Nuwan Kondasinghe, et al.ACS Infectious Diseases|February 24, 2022
Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like CoronavirusesBrendan T Freitas, Daniil A Ahiadorme, Rahul S Bagul, et al.Pageof 27